Response to comment on 'empirical assessment of methods for risk identification in healthcare data'
Stat Med
.
2013 Mar 15;32(6):1075-7.
doi: 10.1002/sim.5725.
Authors
Patrick B Ryan
,
David Madigan
,
Paul E Stang
,
J Marc Overhage
,
Judith A Racoosin
,
Abraham G Hartzema
PMID:
23413215
DOI:
10.1002/sim.5725
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug-Related Side Effects and Adverse Reactions*
Electronic Health Records / statistics & numerical data*
Humans
Pharmacoepidemiology / methods*
Product Surveillance, Postmarketing / methods*